Lisamarie Ruffolo
Nurse Practitioner · Orland Park, ILNPI 1801329743
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,531 of the $12,566 with a category attached, or 67.9%. 29 manufacturers reported payments, led by AbbVie at 48.0% of the total. 2025 is the largest year on record at $5,865, 3.9 times the $1,509 reported in 2021. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 431 payments — averaging $29.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$745
- Corium, LLC$678
- Tris Pharma Inc$591
- Neurocrine Biosciences, Inc.$514
- Johnson & Johnson$506
- plus $4K from 23 others
What the payments were for
- Speaking & faculty fees$3,75030%
- Travel & lodging$1271%
- Food & beverage$8,53168%
- Education$1581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 120 | $6,026 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $745 |
| Corium, LLC | 31 | $678 |
| Tris Pharma Inc | 38 | $591 |
| Neurocrine Biosciences, Inc. | 24 | $514 |
| Johnson & Johnson | 22 | $506 |
| Axsome Therapeutics, Inc. | 17 | $446 |
| Teva Pharmaceuticals USA, Inc. | 15 | $430 |
| Lundbeck LLC | 18 | $354 |
| Otsuka America Pharmaceutical, Inc. | 14 | $327 |
| Vanda Pharmaceuticals Inc. | 10 | $324 |
| Alkermes, Inc. | 13 | $243 |
| E.r. Squibb & Sons, L.L.C. | 10 | $230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $196 |
| Idorsia Pharmaceuticals US Inc | 8 | $137 |
| Ironshore Pharmaceuticals Inc. | 6 | $126 |
| Sunovion Pharmaceuticals Inc. | 9 | $96 |
| Orexo US, Inc. | 5 | $86 |
| Noven Therapeutics, LLC | 4 | $81 |
| Bausch Health US, LLC | 5 | $76 |
| Jazz Pharmaceuticals Inc. | 4 | $70 |
| Indivior Inc. | 3 | $63 |
| Braeburn Inc. | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Biogen | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Livanova USA, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $19 |
| Eisai Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$3,750
How this compares
$12,566 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 50 | $133,809 |
| RexultiBrexpiprazole | 16 | $51,741 |
| TrintellixVortioxetine Hydrobromide | 13 | $7,267 |
| Paliperidone ErPaliperidone | 16 | $5,694 |
| Adderall XrDextroamphetamine/Amphetamine | 18 | $4,488 |
| Duloxetine Hcl | 105 | $4,286 |
| Bupropion XlBupropion Hcl | 127 | $3,633 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 88 | $2,390 |
| Alprazolam | 228 | $2,176 |
| Quetiapine Fumarate | 61 | $1,753 |
| Trazodone Hcl | 134 | $1,499 |
| Hydroxyzine Hcl | 51 | $1,386 |
| Escitalopram Oxalate | 113 | $1,101 |
| Prazosin Hcl | 25 | $988 |
| Buspirone Hcl | 39 | $951 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $6,026 | $133,80950 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $327 | $51,74116 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $196 | $7,26713 claims |
| Almatica Pharma LLCSertraline Hcl | $19 | $67185 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Orland Park
- Kaitlyn RuckmanOrland Park$28K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Erika VuckoChicago$76K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.